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INTRODUCTION
According to a summary of joint surveys on survival rates by the
Japanese Association of Clinical Cancer Centers (1), the 5-year
survival rate, which is the medical standard for evaluating recov-
ery, exceeded 62.5% in all sites.
Majority of cancers are viewed as chronic diseases. However,
lung cancer is usually not discovered early and is characterized by
rapid progression and metastasis. With a 5-year survival rate of less
than 5% for stage IV disease, lung cancer has been perceived as an
intractable disease that accounted for the highest rate of mortality
among all cancers (Ministry of Health, Labour and Welfare) (2).
Lung cancer patients tend to have a large number of psycho-
logical, physical and daily living unmet needs, compared with
patients with cancer of other organs (3). They also undergo illness-
related emotions during diagnosis and at the beginning of therapy
(4), which might be the reason for their strong emotional needs
(5). Over the course of therapy, patients with lung cancer in the
advanced stage experience an overlap of cancer-associated symp-
toms, as well as side effects of chemotherapy, surgery, and radiation
therapy. These myriad of symptoms cause emotions, such as fear
and internal conflict (6). As a consequence, these emotional prob-
lems of advanced lung cancer patients have been linked to reduced
quality of life (QOL) (7, 8). The lung cancer patients had lower QOL
scores than patients suffering from other malignancies (8, 9). This
also suggests that lung cancer patients have serious emotional
problems.
At the same time, uncertainty is defined as the inability to deter-
mine the meaning of illness-related events (10). Advanced lung
cancer patients also experience uncertainty about death (11). The
period from diagnosis to the start of therapy has been acknowledged
by patients as a time of unbearably strong uncertainty. Uncertainty
can also lead to anxiety, which reduces QOL (12). Uncertainty about
what will happen next and about the consequences of an event and
what it means are important to a person with any illness (10).
Managing uncertainty associated with an illness and its treatment
may be an essential task in adaptation (10). Adaptation is defined as
biopsychosocial behavior occurring within a persons’ individually -
defined range of usual behavior (10).
The emotional needs of advanced lung cancer patients are strong,
especially during the period from diagnosis to the start of therapy.
As patients experience wavering emotions due to their symptoms,
their strong uncertainty about death further affects their emotions
and can reduce their QOL. To address this issue on uncertainty,
it is important to understand first the degree of uncertainty and
its effects on an individual patient’s emotions. However, it is not
known about relationship between uncertainty and emotions in ad-
vanced lung cancer patients. In this study, we investigated the re-
lationship between uncertainty and emotions in advanced lung
cancer patients after initial therapy.
METHODS
1. Study participants
The present study was conducted from May 2013 to July 2014.
Selection criteria were (a) being an adult, (b) being diagnosed with
advanced lung cancer, and after initial treatment ; chemotherapy
or/and radiation therapy, (c) being explained about diagnosis and
treatment, (d) being not evaluation of the response to initial ther-
apy, (e) being judged by a physician to have no physical, psycho-
logical, cognitive (i.e., mental illness), or language disorders. Par-
ticipants were given written and verbal explanations on the study
purpose, objectives, and methods ; that participation was volun-
tary ; that refusing to give consent or withdrawing consent halfway
through the study would not negatively affect their treatment or
nursing care ; and that their personal information would be pro-
tected. After consenting to participate in the study, the patients
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were asked to sign a consent form. Eligible consenting partici-
pants were investigated about uncertainty and emotions after initial
therapy. Because this study involved advanced cancer patients
who were at the stage after initial therapy, and before evaluation
of the response to initial therapy, consideration was given to vol-
untary participation and to the health and mental well -being of par-
ticipants by establishing a support system for times of physical and
mental unease during the study. The study was performed in accor-
dance with the Declaration of Helsinki and the study protocol was
approved by the Institutional Review Board of Tokushima Univer-
sity Hospital (approval number : 1500, approval date : 2012/8/20).
2. Methods of data collection
1) Participant attributes
Data on age, sex, disease, histologic type, disease stage, treat-
ment regimen, occupation, and family composition were collected
from medical records.
2) Measuring uncertainty
The Universal Uncertainty in Illness Scale (UUIS) (13) was used
to measure uncertainty, with the approval from its developers. The
UUIS (Cronbach’s α 0.79-0.93), which was developed by Nogawa,
can provide an understanding of uncertainty in both inpatients and
outpatients. The scale comprised 6 factors, including ambiguity of
characteristics of illness (characteristics of illness), complexity of
interpretation of information (interpretation of information), unpre-
dictability recovery from illness (recovery from illness), unpredict-
ability of daily life (daily life), instability of self -confidence in Car-
rying on a struggle against illness (carrying on a struggle against
illness), lack of cues finding meaning in illness (meaning in ill-
ness). Each factor contained 3-8 questions for a total of 26 ques-
tions. Participants answered each question by choosing one option
from a 5-point scale, as follows : false (1 point), somewhat false
(2 points), no opinion (3 points), somewhat true (4 points), and true
(5 points). The score for each factor and the overall score were
added to a cumulative score. The overall score ranged from 26 to
130 points. A higher score indicated a stronger feeling of uncer-
tainty.
3) Measuring emotions
The Profile of Mood States-Brief Form (POMS-Brief Form),
Japanese Version was used to measure various moods and emo-
tions in the participants (Cronbach’s α 0.57-0.88). It is available
commercially and the necessary parts were purchased for this study
(Kaneko Shobo Co., Tokyo, Japan). POMS-Brief Form comprised
6 factors, including tension-anxiety (T-A), depression-dejection
(D), anger-hostility (A-H), vigor (V), fatigue (F), and confusion
(C). Each factor had 5 question items for a total of 30 questions.
Participants answered each question by choosing one option from
a 5-point scale, as follows : not at all (0 points), a little (1 point),
moderately (2 points), quite a bit (3 points), and extremely (4
points). The total score for each factor was calculated as the base
score and was then converted to a standardized score (T-score),
according to the instructions (14). A high T-score meant that the
person had many negative moods with low vigor (14). A T-score
of 40-60 indicated a healthy state (14).
3. Data analyses
1) Analyses of uncertainty
A complete set of answers to all questionnaire items was consid-
ered a valid response. The scores and meansSD for all question
items in the UUIS, as well as those for the six- factor scores and the
overall scores, were calculated. Differences in the total UUIS score
were tested according to participant attributes using the Mann-
Whitney U test.
2) Analyses of emotions
A complete set of answers to all questionnaire items was consid-
ered a valid response. The respective T-scores and the mean score
of the 6 factors of the POMS-Brief Form were calculated. A healthy
T-score range of 40-60 was used as the indicator for analysis (14).
Differences in T-scores among the 6 factors were tested according
to participant attributes using the Mann-Whitney U test.
3) Analyses of the relationship between uncertainty and emotions
The relationship between the total UUIS score and the T-
scores of the 6 factors of the POMS-Brief Form was analyzed by
Spearman’s rank correlation coefficient.
The software SPSS Ver. 23 for Windows was used for statistical
analyses. A p value0.05 was considered significant.
RESULTS
1. Participant attributes (Table 1)
Of the 15 patients who consented to participate in the study, 14
gave valid responses to both the UUIS and POMS-Brief Form. The
mean age of patients was 60.5 years (range 47-71 years) and 57%
were male. Twelve participants were non-small cell lung cancer,
others were small cell lung cancer. All participants had stage IV.
Eight participants received chemotherapy/radiotherapy, others
received chemotherapy.
2. Uncertainty
1) UUIS scores
Participants reported levels of UUIS after initial therapy. The
total UUIS score of each participant ranged from 42 to 109, with a
meanSD of 70.720.9. The score of all 26 UUIS items was 2.7
1.5 (meanSD). In addition, the score of each of the 6 factors were
3.31.5 for characteristics of illness ; 2.61.3 for interpretation
of information ; 2.21.4 for recovery from illness ; 2.91.5 for daily
life ; 2.71.4 for carrying on a struggle against illness ; and 2.4
1.5 for meaning in illness (Figure1).
The percentage of participants who indicated that they felt un-
certain by answering “true” or “somewhat true” to any of the items
among the 6 UUIS factors were 71.4% (10 participants) for charac-
teristics of illness ; 57.1% (8participants) for interpretation of infor-
mation ; 35.7% (5 participants) for recovery from illness ; 64.3%
(9 participants) for daily life ; 42.9% (6 participants) for carrying on
a struggle against illness ; and 57.1% (8 participants) for meaning
in illness.
More than half of the participants answered that they had feel-
ings of uncertainty with regard to 4 question items, including “I
cannot see what course my illness will take (characteristics of
illness)” ; “I do not know how serious my illness is (characteristics
Table1. Demographic data of the study participants
Characteristics n=14
Sex
Male 8
Female 6
Age 60.56.2 (47 -71)
Histological type
non-small cell lung cancer 12
small cell lung cancer 2
Clinical Stage
 14
Therapy
chemotherapy/radiotherapy 8
chemotherapy 6
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of illness)” ; “I think about how much burden will be placed on my
family in the future (daily life)” ; and “I wonder about what caused
my illness (meaning in illness).”
2) Differences in UUIS scores according to participant attributes
UUIS scores did not differ significantly according to sex, occu-
pation, and cohabitating family members. Furthermore, using the
mean age of 60.5 years as a reference, no significant difference was
seen between the groups aged60 and61 years.
3. Emotions
1) Scores for the POMS-Brief Form
Participants reported levels of POMS-Brief Form after initial
therapy. The T-scores for the 6 factors of the POMS-Brief Form
were 50.211.9 (meanSD) for T-A, 49.612.2 for D ; 40.44.9
for A-H ; 41.89.3 for V ; 44.25.8 for F ; and 52.715.2 for C
(Figure 2).
The number of participants who was outside the healthy over-
all T-score range of 40-60 was 4 ; whereas the number of partici-
pants who was outside the healthy range was 3 for T-A, 2 for D, and
4 for C.
2) Differences in the 6 factors of the POMS-Brief Form according
to participant attributes
No significant differences in scores were seen according to sex,
occupation, and cohabitating family members. Furthermore, using
the mean age of 60.5 years as a reference, no significant difference
was seen between the groups aged60 and61 years.
4. Relationship between uncertainty (UUIS) and emotions (POMS-
Brief Form)
In terms of the correlation between the total UUIS score and
the respective T scores of the 6 factors of the POMS-Brief Form
(Figure 3), a strong correlation was seen between total UUIS score
and D (r=0.735, p=0.003). A substantial correlation was also seen
between total UUIS score and T-A (r=0.694, p=0.006). On the other
hand, total UUIS score was not correlated with A-H, V, F, or C.
DISCUSSION
1. Relationship between uncertainty and emotions
In this study population of patients who were diagnosed as ad-
vanced lung cancer and after first - line therapy, a correlation was
seen between total UUIS score and the respective T-scores of the
6 factors of the POMS-Brief Form. When a participant’s uncer-
tainty about illness was strong, the statuses of “D” and “T-A” were
also particularly strong. In lung cancer patients, uncertainty during
Figure 1. Mean of each factor of UUIS
The score for the 6 factors of UUIS were 3.31.5 (meanSD) for characteristics of illness ; 2.61.3 for interpretation of information ; 2.21.4 for
recovery from illness ; 2.91.5 for daily life ; 2.71.4 for carrying on a struggle against illness ; and 2.41.5 for meaning in illness.
Figure 2. Mean of each factor of POMS-Brief Form
T-A : tension-anxiety, D : depression-dejection, A-H : anger -hostility, V : vigor, F : fatigue, C : confusion
The T-scores for the 6 factors of the POMS-Brief Form were 50.211.9 (meanSD) for T-A, 49.612.2 for D ; 40.44.9 for A-H ; 41.89.3 for
V ; 44.25.8 for F ; and 52.715.2 for C
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the stage between diagnosis and start of therapy can result in anxi-
ety and reduced QOL (12). However, the results of this study sug-
gested that uncertainty caused depression and dejection, as well
as anxiety. Anxiety has core symptoms of fear, anticipated concern,
and autonomic symptoms ; whereas the core symptoms of depres-
sion are sadness, hopelessness, and diminished joy and interest.
Anxiety and depression easily prolong recovery, when these inter-
mingle and simultaneously manifest (15). When uncertainty is
strong, both anxiety and depression are thought to manifest for a
prolonged period of time. Furthermore, despite the lack of a clear
relationship of uncertainty with confusion and vitality, prolongation
of anxiety and depression can result in confusion and decrease in
vitality. Confusion signifies a decline in thinking power (14), which
can be a factor that hinders patients from taking on an individually -
defined biopsychosocial behavior during usual daily living.
A healthy T-score range of 40-60 was used as the indicator for
analysis (14). In this study, a cumulative T-score of 40-60 from the
factors of the POMS-Brief Form was considered a healthy range,
suggestive of emotional stability. In the period between diagno-
sis and the start of therapy, patients with advanced lung cancer
manage uncertainty through efforts in finding a way to live amidst
this state of confusion (16). Management of uncertainty between
diagnosis and initial therapy may be important cause of emotional
stability of patients with advanced lung cancer after therapy.
More than half of the participants felt uncertain about at least 1
of the 4 UUIS factors, including characteristics of illness, interpre-
tation of information, daily life, and meaning in illness. We were
able to interpret the situations of patients, including their thoughts
on how the serious status of their advanced lung cancer would
develop, their difficulty in understanding information on their ill-
ness, their lack of outlook on daily life, and their wavering resolve
on the meaning of life with illness. Furthermore, in 4 participants,
the POMS T-score from some factors, such as T-A, D, and C, fell
outside the healthy range. If persistent throughout the subsequent
course of therapy, this state could have a significant effect on emo-
tions ; therefore, it is critical to support patients in managing their
own uncertainty while verifying the details of a patient’s uncertainty.
2. Suggestions for nursing
Cancer experiences, particularly at the stage between diagnosis
and therapy, do not encompass a binary notion of cure versus non-
cure ; the vagaries, phases, and syndromes of survival are far more
complex than that simple idea and patients are commonly con-
fronted with their own deaths (17). Anxiety and depression are
related to the QOL of patients with lung cancer (9). The level of
anxiety often increases during therapy, which is related to decrease
Figure 3. Correlations between UUIS and POMS-Brief Form
In terms of the correlation between the total UUIS score and the respective T scores of the 6 factors of the POMS-Brief Form, a strong correlation
was seen between total UUIS score and D (r=0.735, p=0.003). A substantial correlation was also seen between total UUIS score and T-A (r=0.694,
p=0.006).
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in QOL (9). Patients with advanced lung cancer particularly suffer
strong uncertainty over their potential death, which can lead to
strong expression of negative emotions, including anxiety and de-
pression, and subsequent reduced QOL. The concept of a “cancer
survivor” was based on the experience on the cancer continuum-
living with, living through, and living beyond a cancer diagnosis
(18). It signifies a strong resolve to perceive one’s self as a person
who lives in the present ; for this to happen, a lot of support is
necessary, especially after receiving a diagnosis of cancer (19).
The results of this study revealed a relationship between uncer-
tainty and emotions in patients with advanced lung cancer after
initial therapy, which can make it difficult for these patients to stand
themselves as people who live in the present. This was because
their strong uncertainty greatly affected their emotions. Studies on
support systems that allow individuals to manage uncertainty on
their own are available for patients with other cancers (20) ; a simi-
lar study for advanced lung cancer patients is needed. Support
systems of the uncertainty management could help maintain and
improve the QOL of patients by allowing them to control their
emotions and to move forward as survivors living with cancer.
3. Study limitations
This study had two limitations. First, it was the small number
of subjects who participated in this study. However, we believe that
the result shows an intriguing fact : it suggested that uncertainty
caused depression and anxiety. We need to increase the number
of samples, and validate these results. Another limitation, this study
investigated uncertainty and emotions only after initial treatment.
Therefore, changes at the time when diagnoses were received and
the subsequent course of treatment require investigation. A future
study will also be needed to examine the relationship between un-
certainty and its management by patients.
CONCLUSIONS
In patients with advanced lung cancer after initial therapy, un-
certainty had an effect on emotions and can reduce QOL. Support
that encourages patients to manage their uncertainty on their own
while verifying the details of a patient’s uncertainty is important.
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